Peter A. Thompson, Director at ARS Pharmaceuticals, Inc. (SPRY), bought 500,000 shares at $6.20 ($3.1M) on 2023-08-29, disclosed to the SEC on 2023-08-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SION | SELL | 2026-05-29 | $4K | — | Filing → |
| SION | SELL | 2026-05-11 | $13.4M | — | Filing → |
| SION | SELL | 2026-04-21 | $2.5M | — | Filing → |